Skip to content

Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia

Comparison Between Dexmedetomidine and Midazolam Nebulization as Procedural Sedation During Cesarean Delivery Under Spinal Anesthesia in Pre-eclamptic Parturients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04873596
Enrollment
94
Registered
2021-05-05
Start date
2021-05-15
Completion date
2024-08-01
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Procedural Sedation

Brief summary

Null hypothesis: There is no difference between the effects of nebulization of dexmedetomidine and midazolam as procedural sedation during cesarean delivery under spinal Anesthesia in pre-eclamptic parturients Alternative hypothesis: There is difference between the effects of nebulization of dexmedetomidine and midazolam as procedural sedation during cesarean delivery under spinal anesthesia in pre-eclamptic parturients

Detailed description

Site of study: This study will be carried out in operating theater of obstetrics at Zagazig University Hospitals. Withdrawal Criteria: The woman has the right to withdraw from the study at any time without any negative consequence on their medical or surgical treatment plan. Double -blind randomized clinical trial. All patients will be hospitalized and visited a day before the surgery, full history with physical examination and routine investigation will be done, the nature and complications of the study will be explained in detail to the patient and informed written consent will be obtained from every woman.

Interventions

parturient will receive nebulized 3ug/kg dexmedetomidine.

parturient will receive nebulized 0.2 mg/kg midazolam.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 21-38 years old. * Mild and moderate preeclampsia parturient. * American Society of AnesthesiologistPhysical status II. * Body Mass Index (BMI) (25-35kg/m²). * Type of operations: elective cesarean section under spinal anesthesia. * Written informed consent from the parturient.

Exclusion criteria

* Altered mental state. * Women with known history of allergy to study drugs. * Women with uncontrolled diabetes mellitus, bleeding, coagulation disorders, advanced hepatic, renal, cardiovascular, respiratory disease and neuropsychiatric disorders. * Patients receiving anticonvulsants or antidepressants. * Sever preeclampsia, intrauterine growth restriction or fetal compromise.

Design outcomes

Primary

MeasureTime frameDescription
Chane in the level of sedationat 0 minute (immediately after nebulization) , 5 minutes then every 15 minutes intraoperativeChange in the level of sedation will be assessed using Ramasy Sedation Assessment Scale Ramsay Sedation Scale 1= Patient is anxious and agitated or restless, or both 3= Patient responds to commands only 4= Patient exhibits brisk response to light glabellar tap or loud auditory stimulus 5= Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus 6= Patient exhibits no response

Secondary

MeasureTime frameDescription
Maternal satisfaction with procedureup to 24hour postoperativeMaternal satisfaction with procedure using a 5-point numerical rating scale. 0= Extremely dissatisfied 1. Dissatisfied 2. Neutral 3. Satisfied 4. Extremely satisfied
APGAR scoreat 1 and 5 min after deliveryAPGAR score at 1 and 5 min after delivery APGAR score (13). Indicator Score 0 Score 1 Score 2 Activity (muscle tone) Limp; no movement Some flexion of arms and legs Active motion Pulse (heart rate) No heart rate Fewer than 100 beats per minute At least 100 beats per minute Grimace (reflex response) No response to airways being suctioned Grimace during suctioning Grimace and pull away, cough, or sneeze during suctioning Appearance (color) The baby's whole body is completely bluish-gray or pale Good color in body with bluish hands or feet Good color all over Respiration (breathing) Not breathing Weak cry; may sound like whimpering, slow or irregular breathing Good, strong cry; normal rate and effort of breathing Total Score: 3 and below require immediate resuscitation 4 to 7 may require resuscitative measures 7 to 10 is considered normal
The discharge time from Post Anesthesia Care Unite (PACU) .up to 30 minutes postoperativeThe discharge time from Post Anesthesia Care Unite (PACU) in minutes when achieving modified Aldrete Score 9. Modified Aldert Score. Activity, able to move, voluntarily or on command 4 extremities = 2 2 extremities = 1 No = 0 Breathing Able to breathe deeply & cough freely= 2 Dyspnea, shallow or limited breathing =1 Apnea= 0 Consciousness Fully awake = 2 Arousable on calling = 1 Unresponsive = 0 Circulation (BP) ±20% of pre-anesthesia level= 2 * 20% to 49% of pre-anesthesia level= 1 * 50% of pre-anesthesia level= 0 SPO2 Maintains SpO2 \>92% in ambient air= 2 Maintain SpO2 \>90% with O2 = 1 Maintain SpO2 \<90% with O2 = 0
Mean arterial blood pressureBaseline, at 0 minute (after nebulization), 5 minutes then every 10 minutes intraoperative.Mean arterial blood pressure in mmHg
Oxygen saturationBaseline, at 0 minute (after nebulization), 5 minutes then every 10 minutes intraoperative.Oxygen saturation by pulse oximetry.
Heart rateBaseline, at 0 minute (after nebulization), 5 minutes then every 10 minutes intraoperative.heart rate in beat/ minute

Countries

Egypt

Contacts

Primary ContactAlshaimaa Kamel, M.D
AlshaimaaKamel80@yahoo.com01005593169
Backup ContactDina Abdelhameed Elsadek salem, M.D
dinamagapy@yahoo.com01099333513

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026